PRFX Stock Analysis: Buy, Sell, or Hold?
PRFX - PainReform Ltd. Ordinary Shares
$1.49
0.04 (2.76%)
▲
5d:
-5.7%
30d:
-38.17%
90d:
-50.0%
HOLD
LOW Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: Jun 25, 2026
29d
Get Alerted When PRFX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
9 traders called PRFX this week
45% bullish • 6 bearish
45% bullish • 6 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PRFX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PRFX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PRFX is currently trading at $1.49, which is considered oversold relative to its 30-day fair value range of $1.63 to $2.50.
Technical Outlook: Technically, PRFX is in a uptrend. Immediate support is located at $1.28, while resistance sits at $1.96.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+705.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRFX is in a uptrend. Immediate support is located at $1.28, while resistance sits at $1.96.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+705.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.63 -
$2.50
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 705.4% below Wall St target ($12.00)
- CAUTION: Recommendation downgraded due to -5.7% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.63 -
$2.50
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.28
Resistance Level
$1.96
Current Trend
Uptrend
Technical data as of
May 21, 2026
Fundamental Context
Wall Street Target
$12.00
(+705.4%)
Share & Embed Analysis
Last updated: May 26, 2026 6:29 AM ET
Data refreshes hourly during market hours. Next update: 7:29 AM
Data refreshes hourly during market hours. Next update: 7:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRFX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$192 | 63 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$104 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 56 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 56 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
